| Literature DB >> 33208885 |
Ayako Nishizawa1,2, Kazuki Kumada3, Keiko Tateno4, Maiko Wagata1,2, Sakae Saito2,4, Fumiki Katsuoka2,4, Satoshi Mizuno2,5, Soichi Ogishima2,5, Masayuki Yamamoto2,4, Jun Yasuda4,6, Junichi Sugawara7,8.
Abstract
Preeclampsia is a pregnancy-induced disorder that is characterized by hypertension and is a leading cause of perinatal and maternal-fetal morbidity and mortality. HLA-G is thought to play important roles in maternal-fetal immune tolerance, and the associations between HLA-G gene polymorphisms and the onset of pregnancy-related diseases have been explored extensively. Because contiguous genomic sequencing is difficult, the association between the HLA-G genotype and preeclampsia onset is controversial. In this study, genomic sequences of the HLA-G region (5.2 kb) from 31 pairs of mother-offspring genomic DNA samples (18 pairs from normal pregnancies/births and 13 from preeclampsia births) were obtained by single-molecule real-time sequencing using the PacBio RS II platform. The HLA-G alleles identified in our cohort matched seven known HLA-G alleles, but we also identified two new HLA-G alleles at the fourth-field resolution and compared them with nucleotide sequences from a public database that consisted of coding sequences that cover the 3.1-kb HLA-G gene span. Intriguingly, a potential association between preeclampsia onset and the poly T stretch within the downstream region of the HLA-G*01:01:01:01 allele was found. Our study suggests that long-read sequencing of HLA-G will provide clues for characterizing HLA-G variants that are involved in the pathophysiology of preeclampsia.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33208885 PMCID: PMC7675977 DOI: 10.1038/s41598-020-77081-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary of the study cases.
| Control (n = 13) | PE (n = 18) | p-valuea | |||
|---|---|---|---|---|---|
| Mean (%) | SD | Mean (%) | SD | ||
| Mean, SD | 30.9 | 3.2 | 31.2 | 5.8 | 0.56 |
| % | 30.7 | 38.9 | 0.64b | ||
| Mean, SD | 22 | 4.43 | 22 | 3.15 | 0.5 |
| Mean, SD | 39.3 | 0.95 | 37.3 | 1.36 | < 0.0001 |
| Mean, SD | 3082.6 | 402.8 | 2600.1 | 477.6 | 0.0034 |
SD standard deviation.
aStudent t-test was performed unless otherwise indicated.
bChi-square test.
Figure 1Novel alleles of the HLA-G core region. (A) Schematic of the HLA-G core region. White and gray rectangles indicate noncoding and coding exons, respectively. Lines that connect the rectangles indicate introns. The exon widths are proportional to the actual sizes, but the intron lengths are not. The HLA-G core region (defined based on the known HLA-G alleles registered in the IPD-IMGT/HLA database: https://www.ebi.ac.uk/ipd/imgt/hla/) and the region analyzed in the present study are indicated by the brackets above the exons/introns. The polymorphisms analyzed in this study are indicated by triangles and short descriptions. (B,C) Fluorographs of Sanger sequencing performed to verify the novel HLA-G core region alleles, with sense strand reads shown.
Distribution of HLA-G alleles in preeclampsia and healthy mother–offspring pairs.
| HLA-G | 14 bp | PE | Control | Total | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mother | Offspring | Sum | Inherited | Mother | Offspring | Sum | Inherited | ||||
| 01:01:01:01 | Del | 13 | 13 | 26 | 7* | 7 | 9 | 16 | 4 | 42 | 0.569 |
| New allele 1 | Del | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | NA |
| 01:01:02:01 | + | 7 | 5 | 12 | 4 | 3 | 6 | 9 | 3 | 21 | 1 |
| 01:01:03:03 | + | 4 | 2 | 6 | 2 | 4 | 0 | 4 | 0 | 10 | 1 |
| 01:03:01:02 | + | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0.509 |
| 01:04:01:01 | Del | 9 | 10 | 19 | 3* | 10 | 8 | 18 | 4 | 37 | 0.329 |
| New allele 2 | Del | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | NA |
| 01:04:01:02 | Del | 1 | 4 | 5 | 0 | 1 | 2 | 3 | 1 | 8 | 1 |
| 01:06:01:01 | + | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 0.174 |
Del deletion, NA not analyzed.
*One mother–offspring pair showed the same genotype.
Figure 2Dendrogram of the molecular evolution of HLA-G. The seven major haplotypes of HLA-G found in this study and the corresponding Pan HLA-G sequences (panTro6: chr6: 29,345,638–29,350,879) were analyzed using ClustalW software. We used two G*01:01:01:01 alleles with different T stretch lengths (17 and 43 bp) and two G*01:04:01:01 alleles based on the variant rs17875394. The allelotypes with second field resolution are indicated with different colors: 01:01 as black, 01:03 as orange, 01:04 as gray, and 01:06 as light green. The vertical distance indicates the difference between the alleles, and the horizontal distance indicates the relative timing of the separation among the alleles. The broken line indicates the categories used for the allele frequencies. The presence or absence of the 14-bp insertion is indicated as “positive” in red and “negative” in black on the right side of the panel. The nucleotide lengths of the T stretch (figures longer than 25 are indicated in blue) and the cumulative allele frequencies of each category in our data set are shown on the right side of the panel.
Figure 3Allelic variations in the nucleotide length of the T stretch downstream of HLA-G. (a) Three-dimensional bar graph of the poly T stretch length. The x-axis indicates the nucleotide length of the poly T stretch, and the y-axis indicates the number of chromosomes observed in this study. Chromosomes shared between mother and offspring were counted as one. The z-axis indicates the HLA-G alleles observed in this study. The indexes are shown on the right side of the bar graph. (b) Three-dimensional bar graphs of the T stretch according to the presence or absence of PE and the generation (mother vs. offspring). The statistically significant data for PE offspring (the shortest T stretch associated with G*01:01:01:01) in the rightmost graph are indicated with a red arrow.
Comparison of the length of the poly T-stretch in the G*01:01:01:01 allele between healthy and preeclampsia mother–offspring pairs.
| G*01:01:01:01 | Short | Long | p-value | Odds ratio (95% confidence interval) |
|---|---|---|---|---|
| ≤ 25 bp | > 25 bp | |||
| PE | 10 | 3 | 0.0274 | 11.67 (1.53–89.12) |
| Healthy | 2 | 7 | ||
| PE | 8 | 5 | 0.6424 | 2.13 (0.33–13.81) |
| Healthy | 3 | 4 | ||